ArticleInternational breastfeeding journal2025
Drug exposure during breastfeeding: a descriptive population-based cohort study with SIDIAP database.
Article in International breastfeeding journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is a gap in the knowledge of drug exposure during breastfeeding due to exclusion of lactating individuals from studies. It makes difficult to fully understand the implication of drug use while breastfeeding and potential risks to newborns. Breastfeeding information in the Electronic Health Records (EHR) may help us to increase this evidence. We aimed to describe drug exposure during breastfeeding in mothers of a cohort of mother-infant linked pairs in Catalonia, Spain.
methodsWe conducted a descriptive population-based cohort study including mother-infant linked pairs of infants born during 2010–2022. The data source was the Information System for Research in Primary Care (SIDIAP), including sociodemographic characteristics, comorbidities, prescribed and reimbursed drugs, and lactation registers. Lactation is registered in the infants’ EHR. We analyzed drug exposure from delivery up to 2, 4, 6 and 12 months afterwards. We described categorical variables by absolute frequency and percentage and continuous variables by mean and standard deviation.
resultsWe included 176,324 mother-infant pairs with lactation registers during the first year after birth. Breastfed infants decreased during the first year to 64,225 (36.4%). Drug exposure varied from 76,064 (43.1% of the lactating mothers) from delivery up to month 2, to 32,475 (21.9%), 17,396 (17.6%) and 20,433 (31.8%) at up to months 4, 6 and 12, respectively. The most dispensed drugs were iron (25%), folic acid (15.5%) and analgesics (17.8%). Paracetamol was the most frequent analgesic (89.7%), amoxicillin and fosfomycin were the most frequent antibiotics (92.4% and 89.4%), or ibuprofen the most frequent non-steroidal anti-inflammatory drug (75.6%).
conclusionsThe number of lactating and drug-exposed mothers decreased over time. Iron and supplements were the most used drugs, mainly during the first two months, probably due to continuation since pregnancy or post-partum anemia. Analgesics and penicillins were also frequent, which might be used for common acute conditions. Our main limitation is the potential underreporting of drug exposure due to lack of information on over-the-counter drugs.
trial registration“Drug use in pregnant and breastfeeding women. Outcomes in the health of the women and the offspring”, EUPAS47450, registered at the HMA-EMA Catalogues of real-world data sources and studies: https://catalogues.ema.europa.eu/node/3222/administrative-details .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.